The objective of this study was to evaluate whether copeptin, proANP and proADM levels are higher in patients with OSA and whether they might change under continuous positive airway pressure (CPAP) therapy, serving as potential proxies for the diagnosis and therapy-response in OSA. Here, AVP is linked to obstructive sleep apnea syndrome.